CCT/Parexel is a clinical research site located in Culver City, California, United States 90232.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
CCT/Parexel has participated in 2 clinical trials.
Therapeutic areas: Schizophrenia Patients, Schizophrenia.
Sponsors: Sumitomo Pharma America, Inc..
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
CCT/Parexel has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
CCT/Parexel has 2 clinical trials on record. Their work covers Schizophrenia Patients, Schizophrenia.
CCT/Parexel has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.